CSIMarket
 


Kempharm, Inc  (KMPH)
Other Ticker:  
 
 

KMPH's Net Income Growth by Quarter and Year

Kempharm, Inc's Net Income results by quarter and year




KMPH Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December -6.04 -5.18 -10.57 -9.94
III Quarter September 3.06 -15.07 -9.98 -13.41
II Quarter June -9.26 -9.99 -6.52 9.77
I Quarter March -12.29 -26.22 -16.32 -2.93
FY   -24.53 -56.46 -43.39 -16.51



KMPH Net Income forth quarter 2019 Y/Y Growth Comment
Kempharm, Inc in the forth quarter recorded net loss of $ -6.04 millions.

According to the results reported in the forth quarter, Kempharm, Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Kempharm, Inc' s Net Income no change of % ranks overall at the positon no. in the forth quarter.




KMPH Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Kempharm, Inc's forth quarter 2019 Net Income $ -6.04 millions KMPH's Income Statement
Kempharm, Inc's forth quarter 2018 Net Income $ -5.18 millions Quarterly KMPH's Income Statement
New: More KMPH's historic Net Income Growth >>


KMPH Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Kempharm, Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's IV. Quarter Q/Q Net Income Comment
Current accomplishment of -6.04 millions by Kempharm, Inc look even more unfavourable compare to the 3.06 millions net loss in the previous quarter.

Within Major Pharmaceutical Preparations industry Kempharm, Inc achieved highest sequential Net Income growth. While Kempharm, Inc's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's IV. Quarter Q/Q Net Income Comment
Current results of -6.04 millions by Kempharm, Inc appear even worse if you take a look at 3.06 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Kempharm, Inc achieved highest sequential Net Income growth. While Kempharm, Inc's Net Income growth quarter on quarter, overall rank is .


Kempharm, Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
Cumulative Net Income 12 Months Ending $ -24.52 $ -23.67 $ -41.80 $ -42.54 $ 0.00
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment


Kempharm, Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Kempharm, Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
KMPH's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for KMPH's Competitors
Net Income Growth for Kempharm, Inc's Suppliers
Net Income Growth for KMPH's Customers

You may also want to know
KMPH's Annual Growth Rates KMPH's Profitability Ratios KMPH's Asset Turnover Ratio KMPH's Dividend Growth
KMPH's Roe KMPH's Valuation Ratios KMPH's Financial Strength Ratios KMPH's Dividend Payout Ratio
KMPH's Roa KMPH's Inventory Turnover Ratio KMPH's Growth Rates KMPH's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2019
Resmed Inc   28.82 %$ 28.815 millions
Trillium Therapeutics Inc   27.92 %$ 27.918 millions
China Health Industries Holdings, Inc.  27.69 %$ 27.685 millions
Tenet Healthcare Corp  26.47 %$ 26.471 millions
Msa Safety Inc  25.49 %$ 25.487 millions
Intuitive Surgical Inc   24.51 %$ 24.511 millions
Align Technology inc   24.51 %$ 24.509 millions
West Pharmaceutical Services Inc   22.88 %$ 22.885 millions
Illumina Inc   21.32 %$ 21.320 millions
Chemed Corporation  20.71 %$ 20.711 millions
Teleflex Incorporated  19.51 %$ 19.511 millions
Masimo Corp  12.76 %$ 12.756 millions
Zynex Inc  12.40 %$ 12.395 millions
National Research Corporation  11.50 %$ 11.499 millions
China Biologic Products Holdings Inc   10.43 %$ 10.427 millions
Inspire Medical Systems inc   10.01 %$ 10.012 millions
Redhill Biopharma Ltd   8.97 %$ 8.975 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

QUES's Profile

Stock Price

QUES's Financials

Business Description

Fundamentals

Charts & Quotes

QUES's News

Suppliers

QUES's Competitors

Customers & Markets

Economic Indicators

QUES's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071